All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SRP-1001ARO-DUX4Phase 21 trial

    Sarepta Therapeutics, Inc. · Muscular Dystrophy, Facioscapulohumeral

  • SRP-1003ARO-DM1Phase 21 trial

    Sarepta Therapeutics, Inc. · Myotonic Dystrophy 1

  • SRP1020Phase 21 trial

    Shanghai SciBrunch Therapeutics Co., Ltd. · Advanced Solid Tumors, PARP Inhibitor

  • SRSD216Phase 21 trial

    Sirius Therapeutics Co., Ltd. · Hyperlipoproteinemia (a)

  • SRSD384Phase 21 trial

    Sirius Therapeutics Co., Ltd. · Overweight , Obesity

  • SRX246Phase 21 trial

    Azevan Pharmaceuticals · Aggressive Behavior in Fragile X Syndome

  • SSGJ-613Phase 21 trial

    Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Gout Arthritis

  • SSS06Phase 21 trial

    Shenyang Sunshine Pharmaceutical Co., LTD. · Chemotherapy-induced Anemia, Non-myeloid Malignancies

  • ST-01Phase 21 trial

    Sustained Therapeutics Inc. · Chronic Pain

  • ST-067Phase 21 trial

    Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma

  • ST-920Phase 21 trial

    Sangamo Therapeutics · Fabry Disease

  • ST101Phase 21 trial

    Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer

  • ST266Phase 21 trial

    Noveome Biotherapeutics, formerly Stemnion · Necrotizing Enterocolitis

  • STC-1010Phase 21 trial

    Brenus Pharma · Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer

  • STC-15Phase 21 trial

    STORM Therapeutics LTD · Solid Tumor, Sarcoma, Leiomyosarcoma

  • STI-6129Phase 21 trial

    Zhejiang ACEA Pharmaceutical Co. Ltd. · Relapsed or Refractory Multiple Myeloma

  • STK-012Phase 21 trial

    Synthekine · Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC

  • STM-416Phase 21 trial

    SURGE Therapeutics · Non-muscle-invasive Bladder Cancer

  • STMC-103HPhase 21 trial

    Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity

  • STP705Phase 21 trial

    Sirnaomics · Submental Fullness

  • STRO-002Phase 21 trial

    Tasly Pharmaceutical Group Co., Ltd · Neoplasm Malignant

  • STSA-1301Phase 21 trial

    Jiangsu BioJeTay Biotechnology Co., Ltd. · Primary Immune Thrombocytopenia (ITP)

  • STX-001Phase 21 trial

    Strand Therapeutics Inc. · Advanced Solid Tumor

  • STX-003Phase 21 trial

    Strand Therapeutics Inc. · Advanced Solid Tumor

  • STX-241PFL-241Phase 21 trial

    Pierre Fabre Medicament · Non-small Cell Lung Cancer (NSCLC)

  • STX-721PFL-721, EscalatedPhase 21 trial

    Pierre Fabre Medicament · Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation

  • SUL-238t.i.d.Phase 21 trial

    GEN İlaç ve Sağlık Ürünleri A.Ş. · Parkinson's Disease (PD)

  • SUM-191Phase 21 trial

    Senju USA, Inc. · Bacterial Conjunctivitis

  • SUN-627NEU-627, N-004850Phase 21 trial

    Sundance Biosciences, Inc. · Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS)

  • SV-102Phase 21 trial

    Syncromune, Inc. · Metastatic Castration-resistant Prostate Cancer

  • SV001Phase 21 trial

    Shanghai Synvida Biotechnology Co.,Ltd. · Idiopathic Pulmonary Fibrosis(IPF)

  • SX-682Phase 21 trial

    Syntrix Biosystems, Inc. · Metastatic Castration-resistant Prostate Cancer

  • SXR1096Phase 21 trial

    Sixera Pharma · Netherton Syndrome

  • SYH2059Phase 21 trial

    InnovStone Therapeutics Limited · Idiopathic Pulmonary Fibrosis

  • SYH2062Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mild to Moderate Primary Hypertension

  • SYH2066Phase 21 trial

    CSPC Ouyi Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections

  • SYH2068Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Adult Participants With Elevated Lipoprotein(a)

  • SYH2070Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mixed Hyperlipidemia

  • SYH2085Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Influenza

  • SYH9061Phase 21 trial

    CSPC-NBP Pharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis

  • SYHX2011Phase 21 trial

    CSPC Ouyi Pharmaceutical Co., Ltd. · Advanced Breast Cancer

  • SYL1801Phase 21 trial

    Sylentis, S.A. · Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration

  • SYN-004Phase 21 trial

    Theriva Biologics, Inc. · Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics

  • SYN321Phase 21 trial

    Synartro AB · Osteoarthritis of Knee

  • SYS6006Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors

  • SYS6023Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Breast Cancer

  • SYS6026Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · High-grade Cervical Intraepithelial Lesions

  • SYS6045Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors

  • SYS6062Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)

  • SYS6088Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced/Metastatic Solid Tumors

NewerPage 70 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.